echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Drug companies investing in hospitals: large investment or enclosure

    Drug companies investing in hospitals: large investment or enclosure

    • Last Update: 2013-11-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: since the State Council issued the notice on Further Encouraging and guiding social capital to hold medical institutions in December 2010, the positive policy signals have made all kinds of capital rush to invest in hospitals In this upsurge of investment in hospitals, pharmaceutical enterprises play a mainstay role According to the opinions of several insiders, in addition to the support policies issued in succession, an important consideration for pharmaceutical enterprises to become the main force of hospital layout is to integrate the industrial chain or seek income beyond the main business Under the encouragement of policy, pharmaceutical companies' investment in hospitals looks promising, but after purchasing hospitals, pharmaceutical companies have to face a more difficult problem - how to manage hospitals "The management of the hospital should be a third party with professional hospital management experience, or on the basis of ensuring the general development direction of the hospital remains unchanged, the original management should continue to operate the hospital." A medical industry investor told reporters that in view of the management problems of the hospital, it is necessary to send talents in finance, personnel, legal affairs and other aspects to the hospital Achieve industrial synergy? Compared with A-share market, the investment of other capital in private hospitals is slightly slow According to Zhuang Yiqiang, Deputy Secretary General of China Hospital Association, in addition to the recent support policies, an important consideration is the integration of upstream and downstream of the industrial chain In fact, pharmaceutical enterprises have the advantage of industrial chain coordination, which has also been recognized by many insiders The above investors in the pharmaceutical industry told reporters that many pharmaceutical companies invest in hospitals because they can change "Party B" into "party a" in this way and strengthen the control of the downstream "There are actually two aspects for pharmaceutical companies to consider: on the one hand, making drugs is subject to greater price control, so making hospitals to find new sources of profit; on the other hand, it can hedge upstream and downstream risks." Said the person Liu Yugang, partner of Roland Berger, said that circulation enterprises have certain advantages, are closer to medicine, and can control hospital costs from the perspective of supply chain "Pharmaceutical enterprises get rid of the positioning of distribution, grasp the right of selecting goods of hospitals, and become delivery enterprises, so they have certain advantages But circulation enterprises have no advantages in hospital management " From the perspective of current collaboration with pharmaceutical companies, there may not be many real synergies or mature business models Liu Yugang said that at present, a small number of hospitals can consider their own business and hospital system, such as Ma Yinglong's hemorrhoid treatment products, and the hospitals involved are specialized hospitals related to them In fact, such enterprises have a lot of cooperation "The synergy is not only reflected in procurement, but also in better understanding of patients' needs and treatment methods, and how to optimize the efficacy and reduce side effects." To this end, Ge Jianqiu, a personage in the pharmaceutical industry, holds different views In his opinion, the investment of pharmaceutical enterprises now is more an asset investment behavior, even a land enclosure behavior, when their own products and R & D capabilities are insufficient "At present, the logic of many pharmaceutical companies investing in hospitals is to open up the market for drugs, but it is difficult to form a large scale." Ge Jianqiu said, "from the perspective of the current investment enterprises, many of them are due to their existing products and R & D products are not competitive, so we will see that most of the enterprises that invest in hospitals are basically engaged in general medicine, and few of them invest in hospitals for new drugs In addition, the investment is likely to be for enclosure, because the hospital land is very cheap " After the acquisition, the management pharmaceutical companies have to face more difficult problems, that is, how to manage hospitals "At present, there is a lack of professionalism in hospital management and enterprise management philosophy, such as the opacity of the hospital's financial system, the prevalence of channel rebate, regulatory risks and other issues." "In this way, pharmaceutical companies are also facing great risks in investing in hospitals," the former pharmaceutical investors told reporters In addition, pharmaceutical companies also face another problem: the long return cycle of hospital investment "For general hospitals, whether public or private, the average cost can be recovered in 5-8 years or even longer." Said the investors in the pharmaceutical industry In the view of many insiders, pharmaceutical enterprises are more competitive in seizing the downstream hospitals of their industrial chain, and their familiarity with medical institutions, resources and understanding of the industry are slightly better than other investors outside the industry However, in hospital management, pharmaceutical companies have no advantages From the perspective of several enterprises investing in hospitals at present, only a few enterprises can get good profits by investing in medical institutions In addition to Jinling pharmaceutical's successful acquisition of Suqian people's Hospital, Huayuan Group established a joint venture with Xinxiang Municipal Government in the early stage to take over 5 public hospitals in Xinxiang, Shuanglu pharmaceutical and Xinxiang hospital, and Ping An Group's investment in Shenzhen Longgang District Hospital of traditional Chinese medicine ended in failure or there were integration problems  
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.